15:51 Dec 27
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
Industry Biotechnology
15:51 Dec 27
Quality
75/100
High Financial Strength
Valuation
13/100
Expensive Valuation
Technical
62/100
Technically Moderately Bullish
Strength
12
Weakness
1
Opportunity
1
Threats
1
0.40 %
Dividend Yield
22.65K
Market Cap (Cr)
57.27
RSI
44.08 %
Promoter Holding
30.29 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 21-Jun-2024 | Dividend | 8.75/share@875.00% | 22-Jun-2024 | 875.00 | Final |
Download Our App On:
